Diffuse myocardial fibrosis in early forms of dilated cardiomyopathy: insights from T1 mapping cardiovascular magnetic resonance

Diffuse myocardial fibrosis in early forms of dilated cardiomyopathy: insights from T1 mapping cardiovascular magnetic resonance

Bibliographic Details
Main Authors:	aus dem Siepen Fabian, Seitz Sebastian A, Abdelrazek Mohamed A, Giannitsis Evangelos, Katus Hugo A, Steen Henning, Abdel-Aty Hassan
Format:	Article
Language:	English
Published:	BMC 2013-01-01
Series:	Journal of Cardiovascular Magnetic Resonance

Similar Items

Non-invasive measurement of myocardial extracellular volume using T1 mapping as a novel biomarker of diffuse fibrosis in dilated cardiomyopathy
by: aus dem Siepen Fabian, et al.
Published: (2013-01-01)

Right ventricular function in dilated cardiomyopathy: relation to location of focal myocardial fibrosis
by: Abdelrazek Mohamed A, et al.
Published: (2013-01-01)

2060 RV dimensions in dilated cardiomyopathy in cine-MRI
by: Giannitsis Evangelos, et al.
Published: (2008-10-01)

Bio-imaging: late gadolinium enhancement in hypertrophic cardiomyopathy and its relation to novel biomarkers of fibrosis
by: Abdel-Aty Hassan, et al.
Published: (2012-02-01)

1113 MAPSE and TAPSE measured by MRI correlate with left and right ventricular ejection fraction and NTproBNP in patients with in dilated cardiomyopathy
by: Merten Constanze, et al.
Published: (2008-10-01)

MRI morphological and functional method for clear distinction of patients with left ventricular non-compaction, inflammatory dilated cardiomyopathy and physiological myocardial trabeculation
by: Burger Astrid, et al.
Published: (2012-02-01)

Contrast enhanced delayed myocardial enhancement in patients with end stage liver cirrhosis – further evidence for cirrhotic cardiomyopathy
by: Sauer Peter, et al.
Published: (2009-01-01)

CMR derived MAPSE and TAPSE Measurements in hypertrophic cardiomyopathy: comparison to healthy volunteers
by: Abdel-Aty Hassan, et al.
Published: (2012-02-01)

Diffuse fibrosis in dilated cardiomyopathy results in a shorter myocardial null time
by: Manning Warren J, et al.
Published: (2009-01-01)

Gender related differences in left ventricular remodelling in non-ischemic dilated cardiomyopathy- a structural and functional analysis by cardiovascular magnetic resonance
by: Katus Hugo A, et al.
Published: (2010-01-01)

Left ventricular non-compaction cardiomyopathy in adults – characterisation by cardiac magnetic resonance imaging
by: Katus Hugo A, et al.
Published: (2009-01-01)

Comparison of myocardial infarct size measurements between noncontact mapping and cardiac contrast enhanced MRI
by: Giannitsis Evangelos, et al.
Published: (2009-01-01)

Myocardial fibrosis is not associated with reduced quality of life in patients with dilated or hypertrophic cardiomyopathy
by: Drangova Maria, et al.
Published: (2011-02-01)

The quantification and role of diffuse myocardial fibrosis in familial dilated cardiomyopathy - an equilibrium contrast cmr study
by: Elliott Perry M, et al.
Published: (2011-02-01)

Feasibility of high dose dobutamine stress and scar imaging in high field open MRI in patients with suspected coronary artery disease
by: Petry Phillip G, et al.
Published: (2013-01-01)

Association of LA volumes and mid-wall myocardial fibrosis in the Dilated cardiomyopathy patients
by: Mohiaddin Raad, et al.
Published: (2011-02-01)

Association Between Echocardiographic Non-invasive Myocardial Work Indices and Myocardial Fibrosis in Patients With Dilated Cardiomyopathy
by: Cunying Cui, et al.
Published: (2021-08-01)

Myocardial bridging in patients with hypertrophic cardiomyopathy is not associated with late gadolinium enhancement at cardiac magnetic resonance imaging
by: Hees Tilman A, et al.
Published: (2013-01-01)

Myocardial remodelling and recovery in dilated cardiomyopathy
by: Upasana Tayal, et al.
Published: (2017-10-01)

Myocardial fibrosis is a predictor of atrial fibrillation in dilated cardiomyopathy. Role of cardiovascular magnetic resonance
by: Jorge Claudia, et al.
Published: (2011-02-01)

Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the <it>MYBPC3 </it>gene
by: Lehrke Stephanie, et al.
Published: (2008-10-01)

Comparison of parameters for left ventricular volumes and function between echocardiography and cardiovascular magnetic resonance in a large group of cardiac patients
by: Andre Florian, et al.
Published: (2013-01-01)

Prognostic significance of midwall fibrosis in dilated cardiomyopathy
by: Gulati Ankur, et al.
Published: (2012-02-01)

Hepatic and Renal Failure after Anterior Myocardial Infarction Induced Apical Ventricular Septal Defect
by: Dirk Lossnitzer, et al.
Published: (2010-01-01)

Assessment of right and left ventricular trabeculation in a reference collective: gender and age dependency of myocardial trabeculation
by: Giannitsis Evangelos, et al.
Published: (2011-02-01)

Safety and feasibility of high dose stress dobutamine mri very early after acute myocardial infarction
by: Giannitsis Evangelos, et al.
Published: (2011-02-01)

2077 Detection and differentiation of myocardial delayed contrast enhancement patterns by cardiac mri in patients with end stage renal disease
by: Giannitsis Evangelos, et al.
Published: (2008-10-01)

Characteristics and clinical associations of late gadolinium enhanced cardiovascular magnetic tesonance in lamin A/C, cardiac troponin T and myosin binding protein C gene mutation related cardiomyopathies
by: Franke Jennifer, et al.
Published: (2013-01-01)

303 Strain-encoded (SENC) imaging of myocardial function after acute myocardial infarction
by: Katus Hugo A, et al.
Published: (2008-10-01)

Myocardial fibrosis in hypertrophic cardiomyopathy
by: Patel, Vimal
Published: (2018)

Feature tracking cardiac magnetic resonance imaging for the evaluation of myocardial strain in patients with dilated cardiomyopathy and in healthy controls
by: Breuninger Kristin, et al.
Published: (2013-01-01)

THE BLOOD FLOWS IN THE LEFT VENTRICLE AS PREDICTORS FOR MYOCARDIAL DYSFUNCTION IN DILATED CARDIOMYOPATHY
by: V. A. Sandrikov, et al.
Published: (2014-05-01)

Nitro-Oleic Acid (NO<sub>2</sub>-OA) Improves Systolic Function in Dilated Cardiomyopathy by Attenuating Myocardial Fibrosis
by: Simon Braumann, et al.
Published: (2021-08-01)

Prevalence of increased myocardial extracellular volume fraction in dilated cardiomyopathy
by: Lundin Magnus, et al.
Published: (2013-01-01)

Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography
by: Sanders Prashanthan, et al.
Published: (2011-02-01)

Characteristics and Prognostic Importance of Myocardial Fibrosis in Patients with Dilated Cardiomyopathy Assessed by Contrast-Enhanced Cardiac Magnetic Resonance Imaging
by: Jen-Li Looi, et al.
Published: (2010-01-01)

Characteristics and Prognostic Importance of Myocardial Fibrosis in Patients with Dilated Cardiomyopathy Assessed by Contrast-Enhanced Cardiac Magnetic Resonance Imaging
by: Jen-Li Looi, et al.
Published: (2010-12-01)

Influence of presence and patterns of late gadolinium enhancement on left ventricular remodeling after heart transplantation
by: Braggion Santos Maria, et al.
Published: (2013-01-01)

Inter- Not Intraindividual Differences in sTWEAK Levels Predict Functional Deterioration and Mortality in Patients with Dilated Cardiomyopathy
by: Kai-Uwe Jarr, et al.
Published: (2014-01-01)

Dilated cardiomyopathy
by: McKenna, Charles J.
Published: (1999)